rs58124832

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021098.3(CACNA1H):​c.5612G>A​(p.Arg1871Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0573 in 1,561,046 control chromosomes in the GnomAD database, including 3,036 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1871L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.045 ( 230 hom., cov: 34)
Exomes 𝑓: 0.059 ( 2806 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.23

Publications

20 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018953979).
BP6
Variant 16-1218376-G-A is Benign according to our data. Variant chr16-1218376-G-A is described in ClinVar as Benign. ClinVar VariationId is 585651.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.072 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5612G>A p.Arg1871Gln missense_variant Exon 33 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5612G>A p.Arg1871Gln missense_variant Exon 33 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.5627G>A p.Arg1876Gln missense_variant Exon 32 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.5630G>A p.Arg1877Gln missense_variant Exon 32 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5594G>A p.Arg1865Gln missense_variant Exon 32 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.5627G>A p.Arg1876Gln missense_variant Exon 33 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5612G>A p.Arg1871Gln missense_variant Exon 33 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.5573G>A p.Arg1858Gln missense_variant Exon 33 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5594G>A p.Arg1865Gln missense_variant Exon 32 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.5555G>A p.Arg1852Gln missense_variant Exon 32 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5612G>A p.Arg1871Gln missense_variant Exon 33 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5594G>A p.Arg1865Gln missense_variant Exon 32 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5612G>A p.Arg1871Gln missense_variant Exon 33 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.5612G>A p.Arg1871Gln missense_variant Exon 33 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.5612G>A p.Arg1871Gln missense_variant Exon 33 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.5612G>A non_coding_transcript_exon_variant Exon 33 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1564G>A non_coding_transcript_exon_variant Exon 32 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*693G>A non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3463G>A non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5056G>A non_coding_transcript_exon_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*586G>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*471G>A non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1224G>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*279G>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*279G>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5594G>A non_coding_transcript_exon_variant Exon 32 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.5612G>A non_coding_transcript_exon_variant Exon 33 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5612G>A non_coding_transcript_exon_variant Exon 33 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*728G>A non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1564G>A 3_prime_UTR_variant Exon 32 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*693G>A 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3463G>A 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5056G>A 3_prime_UTR_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*586G>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*471G>A 3_prime_UTR_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1224G>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*279G>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*279G>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711488.1 linkn.*728G>A 3_prime_UTR_variant Exon 33 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.0451
AC:
6863
AN:
152190
Hom.:
229
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00914
Gnomad AMI
AF:
0.169
Gnomad AMR
AF:
0.0400
Gnomad ASJ
AF:
0.0838
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0778
Gnomad FIN
AF:
0.0488
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0645
Gnomad OTH
AF:
0.0559
GnomAD2 exomes
AF:
0.0548
AC:
9431
AN:
172182
AF XY:
0.0588
show subpopulations
Gnomad AFR exome
AF:
0.00844
Gnomad AMR exome
AF:
0.0302
Gnomad ASJ exome
AF:
0.0870
Gnomad EAS exome
AF:
0.000168
Gnomad FIN exome
AF:
0.0489
Gnomad NFE exome
AF:
0.0648
Gnomad OTH exome
AF:
0.0667
GnomAD4 exome
AF:
0.0586
AC:
82512
AN:
1408738
Hom.:
2806
Cov.:
33
AF XY:
0.0597
AC XY:
41527
AN XY:
695890
show subpopulations
African (AFR)
AF:
0.00741
AC:
237
AN:
31992
American (AMR)
AF:
0.0312
AC:
1146
AN:
36738
Ashkenazi Jewish (ASJ)
AF:
0.0878
AC:
2224
AN:
25338
East Asian (EAS)
AF:
0.000192
AC:
7
AN:
36374
South Asian (SAS)
AF:
0.0840
AC:
6692
AN:
79712
European-Finnish (FIN)
AF:
0.0503
AC:
2450
AN:
48662
Middle Eastern (MID)
AF:
0.0781
AC:
446
AN:
5708
European-Non Finnish (NFE)
AF:
0.0607
AC:
65913
AN:
1085618
Other (OTH)
AF:
0.0580
AC:
3397
AN:
58596
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
5100
10201
15301
20402
25502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2376
4752
7128
9504
11880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0451
AC:
6865
AN:
152308
Hom.:
230
Cov.:
34
AF XY:
0.0438
AC XY:
3259
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00912
AC:
379
AN:
41570
American (AMR)
AF:
0.0400
AC:
612
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0838
AC:
291
AN:
3472
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5178
South Asian (SAS)
AF:
0.0785
AC:
379
AN:
4830
European-Finnish (FIN)
AF:
0.0488
AC:
518
AN:
10616
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.0645
AC:
4387
AN:
68012
Other (OTH)
AF:
0.0549
AC:
116
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
352
704
1055
1407
1759
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0569
Hom.:
440
Bravo
AF:
0.0400
TwinsUK
AF:
0.0593
AC:
220
ALSPAC
AF:
0.0576
AC:
222
ESP6500AA
AF:
0.00853
AC:
36
ESP6500EA
AF:
0.0583
AC:
489
ExAC
AF:
0.0410
AC:
4646
Asia WGS
AF:
0.0300
AC:
105
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28933792) -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
20
DANN
Benign
0.93
DEOGEN2
Benign
0.090
T;.;.;.
Eigen
Benign
-0.73
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.098
N
LIST_S2
Benign
0.73
T;T;T;.
MetaRNN
Benign
0.0019
T;T;T;T
MetaSVM
Benign
-0.40
T
MutationAssessor
Benign
1.7
L;.;.;.
PhyloP100
1.2
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.63
N;.;N;N
REVEL
Benign
0.28
Sift
Benign
0.49
T;.;T;T
Sift4G
Benign
0.89
T;.;T;T
Polyphen
0.16
B;.;B;B
Vest4
0.24
ClinPred
0.0021
T
GERP RS
1.0
Varity_R
0.068
gMVP
0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58124832; hg19: chr16-1268376; COSMIC: COSV52357919; COSMIC: COSV52357919; API